Title : Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.

Pub. Date : 2020 Oct 20

PMID : 32800552






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib is a multiple tyrosine kinase targeting vascular endothelial growth factor receptor-2 (VEGFR2), EGFR, and the rearranged during transfection (RET) proto-oncogene. vandetanib kinase insert domain receptor Homo sapiens
2 Vandetanib is a multiple tyrosine kinase targeting vascular endothelial growth factor receptor-2 (VEGFR2), EGFR, and the rearranged during transfection (RET) proto-oncogene. vandetanib kinase insert domain receptor Homo sapiens